# Relative Bioavailability of of Olodaterol and Ketoconazole

> **NCT01153711** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 32 (actual)

## Conditions studied

- Healthy
- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** BI 1744
- **DRUG:** BI 1744
- **DRUG:** Ketoconazole
- **DRUG:** Ketoconazole

## Key facts

- **NCT ID:** NCT01153711
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-08
- **Final completion:** —
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01153711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01153711, "Relative Bioavailability of of Olodaterol and Ketoconazole". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01153711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*